Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up

Similar documents
Urine Drug Testing Methods 3-5

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia

The Drug Testing Process. Employer or Practice

Forensic Toxicology Scope of Testing and Detection Limits

Test Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine

Patient-Centered Urine Drug Testing. Douglas Gourlay, MD, MSc, FRCPC, FASAM

September HCMC Toxicology Transition: Additional information and Frequently Asked Questions

10/16/2017. Objectives. Drug Testing Interpretation in Addiction Care. Background. Which is Nonadherent?

Controlled Substance Monitoring in the Age of the Opioid Epidemic

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain

Urine drug testing it s not always crystal clear

Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies

Test Definition: PCDSO Pain Clinic Drug Screen, Urine

You Can t Fool the Bladder Police. Effective Use of Urine Drug Screening

Physician s Reference for Urine and Blood Drug Testing and Interpretation

Pain Medication Management Program Monitors Patient Compliance

3/8/2018. Reasons for Doing UDT. UDT: A Tool in Risk Assessment. Faculty/Presenter Disclosure. Urine Drug Testing in Chronic Pain Management

Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082

EDUCATIONAL COMMENTARY rd TEST EVENT Chemistry Urine Drug Testing

The Utility of Urine Drug Screening

Urine Drug Screening: The Essentials of Interpretation

Drug Adherence Assessment Report

Pain Medication Management Program Supports Patient Outcomes and Adherence

Urine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

DrugSmartCup & DrugSmartDip Accuracy Report as produced by Ameditech, Inc.

Laboratory Service Report

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017

Testing for Controlled Substances

Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens

Drug Testing: How to Evaluate Results

What Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital

QuickTox Drug Screen Dipcard (with and without Adulteration Tests)

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J.

QuickTox Drug Screen Dipcard (with and without Adulteration Tests)

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population

Drug Screening: Things You Need to Know

Urine Opioid Dependency Panel (UODP) 1

SmartNotes. Understanding the SAMHSA Guidelines for Drugs of Abuse Testing

Prepared by Date Adopted Supersedes Procedure # Review Date Revision Date Signature. Distributed to # of Copies Distributed to # of Copies

Caring for ME Webinar: Urine Drug Screening Speaker: Dr. Jonathan Fellers Tuesday, November 20, PM

Multi-Drug Screen Test

A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS

ToxCup Drug Screen Cup Step-by Step Instructions

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS

Overview. Opioids and HIV Infection: From Pain Management to Addiction Treatment

LCMS-8050 Drugs of Abuse: 113 Analytes with Polarity Switching

Conflict of Interest Disclosure

Lyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory.

CDIA TM Marijuana Colloidal Gold Test Cassette (Saliva)

Fastect II Drug Screen Dipstick Test Training and Certification Program

Urine Drug Testing (UDT) in Pain Management. Nov 27, 2017

A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography

Drug Testing Basics. by Erowid

Pain Management and Compliance Toxicology. Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX

Urine Drug Testing (UDT) to Monitor Opioid Use. Feb 2018

Gold Standard for Urine Drug Testin Urine Drug Testing Why U rine? Urine?

Learning Objectives. Drug Testing 10/17/2012. Utilization of the urine drug screen: The good, the bad, and the ugly

Toxicology 101. Arizona Problem Solving Courts April 25, 2016

Welcome - SAMHSA s Role. Welcome SAMHSA Key Messages 4. Welcome SAMHSA s Direction

Drug Screening. Separating Facts from Myths

ToxCup Drug Screen Cup (with and without Adulteration Tests) Training and Certification Program

WELCOME! 12/13/2018. Today s Topic: Urine Drug Screens in OUD Treatment UW PACC

DRUGS OF ABUSE

nextgen precision Test Report

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

Contract No. 952-M1 Collection Service Requirements Texas Department of Criminal Justice (TDCJ)

LC Application Note. Dangerous driver?

Detection of Drugs-of-Abuse by Tandem Mass Spectrometry.

NeoSal Oral Fluid Collection System Solutions for Forensic Drug Detection

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY

Substance Abuse Testing Electronic Result Reporting Layout Specifications. Version 3.2 January 2004

Pharmacokinetics and Disposition of UDM Comparison of Various Sources for Drug Testing: Urine, Blood, Hair, Saliva. Edward J. Cone, Ph.D.

Case Plan Drug Testing: Myths, Best Practices, and Strategies

DRUGS OF ABUSE TEST CUPS 14-DRUG PANEL WITH ADULTERANTS Step by Step Instructions

Validation of a Benzodiazepine and Z-Drug Method Using an Agilent 6430 LC/MS/MS

E XCEL LENCE JUST GOT BETTER UCT FORENSICS CLEAN SCREEN XCEL SPE COLUMNS

T R A I N I N G G U I D E

Schedule of Accreditation

Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations. Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K.

Does ultram show up as an opiate

Drugs of Abuse I Serum

Urine Drug Testing (UDT) in Pain Management. Nov 5, 2017

ToxCup Drug Screen Cup (with and without Adulteration Tests) Training and Certification Program

Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples

DrugConfirm Advanced Urine Dip Cards.

Controlled Substances Evidence-based Tips for Improved Workflow: Diagnosis, Screening & Drug Testing

Rapid Drug Test Cup Step-by Step Instructions

Community Drug Early Warning System (CDEWS-3): Washington, DC - Site 3 of 4

1. Amphetamine (Adderall, desoxyn, Dexedrine,dextrostat, spancap, oxydess II)

Rapid LC/TOF MS for Analytical Screening of Drugs in the Clinical Research Lab

Cutoff levels for hydrocodone in a blood test

EDUCATIONAL COMMENTARY METHADONE

INTERPATH LABORATORY, INC. TEST UPDATES

LABORATORY TECHNICAL SPECIFICATIONS MANUAL

Rapid Spot Tests for Detecting the Presence of Adulterants in Urine Specimens Submitted for Drug Testing

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY

Transcription:

Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up Dr. Bhushan M. Kapur Associate Professor Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, ON CPSO 15nov13 Tables Table 1: Impact of half-life Amount of drug left in the body Amount of drug eliminated Start 100% 0% End of 1 st half-life End of 2 nd half-life End of 3 rd half-life End of 4 th half-life End of 5 th half-life End of 6 th half-life End of 7 th half-life 50.0% 25.0% 12.5% 6.25% 3.125% 1.56% 0.78% 50.0% 75.0% 87.5% 93.75% 96.87% 98.44% 99.22% Caution: Half-life can often be misleading. The duration of detection is dependent on amount taken larger the amount taken longer is the detection period going to be. Sensitivity of the analytical method more sensitive the method the longer is the detection period. Table 2: Poppy seed Bagel and Immunoassay Seven volunteers ate poppy seed covered bagel (one each). Urine was collected and tested for opiates by using immunoassay (CEDIA) method on a Hitachi 717 analyser followed by Remedi-HS HPLC. Male, 30, 140lbs M, 40, 200lbs M, 50, 160 lbs. M, 40, 165 lbs. F, 40, 125 lbs. F, 25, 105 lbs. F, 35, 135 lbs. Before bagel 57 54 51 62 54 38 0 2 hours post 1888 499 >5000 1170 5906 2198 1888 6-8 h post 1924 905 3345 2081 3119 2858 1723 Bedtime 12h post 951 292 NA NA 911 1332 301 First morning void 192 359 564 Na 191 1101 885 24h post Following morning 48 h post 317 107 439 99 46 84 943 * ng/ml. Positive >300 ng/ml. Three of the highest concentrations were subjected to HPLC screen and were negative for any opioids. 1997-2013 Bhushan Kapur All rights reserved 1

Table 3: Descriptive Statistics for reference ranges 1. n mean min max Std dev 95% reference range ph 5464 5.9 5.0 9.0 0.92 Cr mmol/l 5477 11.6 0 50.2 6.5 >2 Na 5474 115 6 353 56 20-230 Cl 5474 130 7 374 62 15-250 1 Bhushan Kapur et al.: Urine Fingerprinting - Detection of Sample Tampering in an Opiate Dependency Program, Ther Drug Mon, 21: 243-250, (1999). Table 4: Effects on EIA including CEDIA procedures. Summary of adulteration studies in Literature and our Lab. Amp Barb Benz Coc Opi PCP THC Marker Bicarbonate - - - - - - - ph, Na Bleach 1% - + - + - - + Na, Cl, Bleach 10% ++ ++ ++ ++ ++ ++ ++ smell Detergent - ++ ++ ++ ++ ++ ++ ph Drano 0.1% - - - - - - ++ ph Drano 20% ++ ++ ++ ++ ++ ++ ++ Golden seal tea - - - - - - ++ dark color Lemon Juice - + + + + - + ph Salt - - - - - - - Vinegar - - - + - - + ph Visine - + + + - - ++? Water loading* (in-vivo) Liquid soap Na, Cl, SpGr ± ± ± ± ± ± ± Cr, SpGr cloudy ++ = strong interference; + = weak interference; - = no interference Although these interferences have been reported in literature, they are dependent on the amount added to the urine. *Water loading or in-vivo dilution is the most common form of adulteration. 1997-2013 Bhushan Kapur All rights reserved 2

Table 5: Drug half-lives and approximate urine detection periods Methamphetamine 12 to 34 hours 2-3 days 1) If Enzyme Immunoassay (EIA) is positive, confirmation by chromatography is required because of high incidence of false positives; Amphetamine (metabolite of methamphetamine) Methyenedioxymethamphe tamine (MDMA) (aka Ecstasy) 7-34 hours 2) EIA cross-reacts with phenylpropanolamine, ephedrine, pseudoephedrine, bromphenriamine, bupropion, tradazone, chlorpromazine, promethazine, ranitidine etc.; (see tables 6 & 6a) 7.6 hours 2 to 3 days 3) MDMA, MDA will be positive with the new generation Ecstasy EIA assay but will also cross-react with amphetamine derivatives as in (2). 4) Chromatography required in differentiating amphetamine derivatives such as MDA and MDMA. Opiates *** 1.3 to 6.7 hours Opiates positive for 2-4 days (EIA)*** 1) EIA does not differentiate between opiates, and has a poor sensitivity for oxycodone, meperidine Morphine (morphine) 2) Chromatography required in identifying specific opiates (codeine, oxycodone, hydrocodone etc (metabolite of Heroin, Codeine, Hydromorphone, hydrocodone) 3) Hydromorphone requires sample extraction modification. 4) Even one poppy seed bagel will be detected on EIA ( see table 5 below). 5) a small amount of morphine is biotransformed into hydromorphone but not to Oxymorphone About 10% of codeine is transferred to morphine in normal metobolizers. False positive reported in literature: quinolones 1997-2013 Bhushan Kapur All rights reserved 3

Oxycodone 4 to 6 hours Not detected by opiate immunoassay specific assay required (now available) Fentanyl IV=2.5min, Intranasal=6.5min Transdermal 7h (3-12h) Not detected by opiate immunoassay. Specific immunoassay recently introduced 1) 33-66% of single dose eliminated in 24 hours. 2) Chromatography will identify Oxycodone and or its metabolites Large amount will give positive on some opiate immunoassays. Immunoassay recently introduced Chromatography will identify both fentanyl and nor-fentanyl Fentanyl is 80% to 85% protein bound Heroin 60 to 90 minutes minutes Not detected in urine. Positive for opiate (morphine) is indicative of probable Heroin use. 6-Mono-acetyl-morphine (MAM) 30 minutes few hours MAM: Detected by chromatography Specific immunoassay is available Phencyclidine (PCP) 7 to16 hours 2 to 3 days Positive incidences are very rare. Cocaine 0.5 to 1.5 hours few hours Cocaine not detected by EIA detected by chromatography Benzoylecgonine detected by EIA, chromatography. Benzoylecgonine (metabolite of cocaine) 5 to 7 hours 3 to 5 days δ 9 -Tetrahydrocannabinol (THC) δ 9 -Tetrahydrocannabinoic acid (marijuana metabolite in urine) 14 to 38 hours 90% fall in 1 hour (blood) much longer (60h) in chronic heavy users Few days to many weeks depending on chronicity of use i) Benzodiazepines few hours to days days -weeks (depending on half-life) Diazepam 15 to 40 hours 2 weeks or more after last chronic use of diazepam Parent drug not detected in urine Detected as Cannabinoids by EIA. False positive reported NAIDS naproxen and ibuprofen i) EIA does not differentiate between different benzodiazepines. Some short acting agents have poor sensitivity. - Oxaprozin (Daypro) can cause a false positive. - Gravol can cause false positive - sertraline can cause false positive 1997-2013 Bhushan Kapur All rights reserved 4

ii) Clonazepam 19 to 60 hours Poor to not detected ii)extensive bio transformed, less than 0.5% excreted in urine over 24 hours sometime visible on hydrolysis and GCMS if chronic dosing is involved iii) Flunitrazepam (date rape drug Rohypnol)**** 9 to 25 hours Not differentiated by immunoassay iii) Need to test for the amino derivative of Flunitrazepam by chromatography. iv) Extensive metabolized. 2% excreted unchanged in urine iv) Bromazepam v) Lorazepam 10-20 hours 9-16 hours Poor 122% cross reactivity but dosage very low Methadone 15 to 40 hours. (Lit) 1 to 4 days. In chronic users urine should always be positive EDDP (Methadone metabolite) In chronic users halflife 27+8h (BK studies) Half-life similar to methadone Barbiturate (Phenobarbital) 35 to120 hours 1 to 2 weeks after last use (Phenobarbital) Alcohol (Ethanol) Blood levels fall by an average of 3.2 to 3.9 mmol/l/hour Or 15 to18 mg/100 ml/hour in social drinkers. Can be much higher in heavy drinkers. Can be 30mg/100mL/hr (BK data) 1.5 > 12 hours depending on the peak blood level. Urine typically positive for 1 to 2 hours after BAC is zero. v) hydrolyzed urine: GCMS can differentiate between diazepam, nordiazepam, oxazepam and lorazepam At alkaline ph methadone is reabsorbed in the kidney. Chromatography or specific EIA required to distinguish methadone from its metabolite EDDP False positive reported: Diphenhydramine, Phenylpropanolamine, clomipramine, chlorpromazine, quetiapine and thioridazine, verapamil EDDP not affected by urine ph (better marker for compliance monitoring) Chromatography required to differentiate between various barbiturates False positive reported NAIDS naproxen and ibuprofen 1. During absorption phase urine level lags behind blood level i.e. BAC is higher than UAlc. 2. During elimination phase blood levels lags behind urine level i.e. UAlc is higher than BAC 1997-2013 Bhushan Kapur All rights reserved 5

# Ethyl Glucuronide 2 to 3 hours Depends on use. Lit. reports up to 120h if LCMSMS (0.1mg/L) is used. 25-30 h (by EIA - BK data) Gamma-Hydroxybutyrate (GHB) (date rape drug) 0.02% of ethanol is excreted as ETG. 0.3 to 1.0 hour Less than 12 hours Chromatography required. Detected as GHB lactone EIA Enzyme immunoassay * R.C. Baselt: Disposition of Toxic Drugs and Chemicals in Man, Fifth Edition 2000 ** The detection period is very much dose and half-life dependent. The larger the dose, the longer the period the drug/metabolite can be detected in the urine. *** Opiates may be positive for up to 2 weeks after last use with slow release opiates. **** Flunitrazepam (Rohypnol) is usually not detected with the generic EIA benzodiazepine procedure. Use chromatography to detect Amino-Flunitrazepam 1997-2013 Bhushan Kapur All rights reserved 6

Figure 6: Specific Gravity - Ur Creatinine Figure 7: Urine Temperature 37 36.5 36 35.5 35 34.5 34 Kapur 1989 0 5 10 15 20 25 30 35 40 45 50 Seconds Temperature Regression 1997-2013 Bhushan Kapur All rights reserved 7